VRAX
Virax Biolabs Group LtdCompany with tickers: VRAX
CIK
1885827
CUSIP
G9495L125
Shares Outstanding
7,423,432
Website
https://viraxbiolabs.com
Investor Relations
https://ir.viraxbiolabs.com/
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2024-12-23 | — | |
| 6-K | 2025-02-25 | — | |
| 6-K | 2025-03-05 | — | |
| 6-K | 2025-03-13 | — | |
| 6-K | 2025-03-18 | — | |
| 6-K | 2025-06-13 | — | |
| 20-F | 2025-07-02 | 2025-03-31 | |
| 6-K | 2025-07-30 | — | |
| 6-K | 2025-12-02 | — | |
| 6-K | 2025-12-04 | — | |
| 6-K | 2026-01-30 | — | |
| 6-K | 2026-03-18 | — | |
| 6-K | 2026-04-10 | — | |
| 6-K | 2026-04-14 | — | |
| 6-K | 2026-05-22 | — | |
| 6-K | 2026-05-26 | — | |
| 6-K | 2026-06-12 | — |
Showing 51–67 of 67 filings